A sustainable and heterogeneous catalytic reductive amination process is developed in the presence of heterogeneous zirconium-based catalysts, in which N , N -dimethylformamide (DMF) is used as the solvent, the low-molecular-weight amine source, and the reductant.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: